[3-(2-Furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid
|
- $467 - $1545
- Product name: [3-(2-Furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid
- CAS: 1105192-61-7
- MF: C10H8N2O4
- MW: 220.18
- EINECS:
- MDL Number:MFCD16652644
- Synonyms:[3-(2-Furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid;2-[3-(Furan-2-yl)-6-oxo-1,6-dihydropyridazin-1-yl]acetic acid;2-(3-(Furan-2-yl)-6-oxopyridazin-1(6H)-yl)acetic acid;1(6H)-Pyridazineacetic acid, 3-(2-furanyl)-6-oxo-
3 prices
Selected condition:
Brand
- Matrix Scientific
Package
- 1g
- 2.500g
- 5g
- ManufacturerMatrix Scientific
- Product number136437
- Product description[3-(2-Furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid 95%+
- Packaging1g
- Price$467
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number136437
- Product description[3-(2-Furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid 95%+
- Packaging2.500g
- Price$1021
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number136437
- Product description[3-(2-Furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid 95%+
- Packaging5g
- Price$1545
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Matrix Scientific | 136437 | [3-(2-Furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid 95%+ | 1g | $467 | 2021-12-16 | Buy |
| Matrix Scientific | 136437 | [3-(2-Furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid 95%+ | 2.500g | $1021 | 2021-12-16 | Buy |
| Matrix Scientific | 136437 | [3-(2-Furyl)-6-oxopyridazin-1(6{H})-yl]acetic acid 95%+ | 5g | $1545 | 2021-12-16 | Buy |
Properties
Boiling point :421.0±51.0 °C(Predicted)
Density :1.46±0.1 g/cm3(Predicted)
storage temp. :Store at Room Tem.
pka :3.60±0.10(Predicted)
Density :1.46±0.1 g/cm3(Predicted)
storage temp. :Store at Room Tem.
pka :3.60±0.10(Predicted)
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




